SHANGHAI, Oct. 30 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company, with operations in China and the United States, today announced that it had received the 2009 Excellence Award from Schering-Plough.
(Logo: http://www.prnasia.com/sa/2009/04/01/200904011147.jpg )
The award recognizes WuXi's contributions to Schering-Plough's success in a range of research projects, from the creation of compound libraries to medicinal chemistry. The partnership has grown in size and scope from a handful of employees four years ago to a large, multidisciplinary team today. WuXi has consistently exceeded Schering-Plough's expectations and earned high customer satisfaction ratings. By developing a comprehensive internal training system, implementing efficient project management, and kindling a collaborative team spirit, the WuXi team has overcome numerous hurdles.
"We are pleased and honored to receive this award from Schering-Plough in recognition of the efforts of our talented and dedicated team of scientists," commented Dr. Ge Li, Chairman and CEO of WuXi AppTec. "Commitment to excellent customer service drives everything we do."
For more information, please contact:
Ronald Aldridge
Director of Investor Relations
WuXi PharmaTech (Cayman) Inc.
Tel: +1-201-585-2048
Email: Ron_Aldridge@wuxiapptec.com
Stephanie Liu (for the media)
Tel: +86-21-5046-4362
Email: pr@wuxiapptec.com
